Tilpisertib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tilpisertib, covering 2022-08-24 to 2022-08-24. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 2]